SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Thalia Therapeutics says patent granted for Miristen in China

Reuters says Thalia Therapeutics PLC has received a new patent grant for Miristen in China. Phase 1 results for Miristen are expected in H1 2027.

THAT.L

Related stories